Biotech & Bioprocessing

I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development. With a sharp focus on technology and innovation, Ivan has been at the forefront of advancing biologics formulation, particularly in tackling the complex challenges of

In the high-stakes world of biopharmaceuticals, where developing a single drug can cost upwards of $2.7 billion, inefficiencies in clinical bioanalysis pose a significant threat to timelines and budgets, often delaying critical decisions by weeks or even months. Traditional manual methods,

In the rapidly evolving field of cellular biology, a groundbreaking advancement has emerged that promises to reshape the study of migrasomes, a unique type of organelle critical to cell communication and various physiological processes. These organelles, formed by migrating cells, play essential

The intersection of artificial intelligence and synthetic biology has unlocked groundbreaking possibilities, but it also casts a dark shadow over global biosecurity, as highlighted in a pivotal study recently published in Science . This research reveals how AI-powered generative protein design

In the rapidly advancing realm of synthetic biology, a remarkable innovation is capturing the attention of scientists and industry leaders alike: the potential to produce proteins outside the confines of living cells using synthetic transfer RNA (tRNA) arrays. This cutting-edge development,

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the world of Tissue Regenix Group, a key player in regenerative